Stock Evaluator: MediPal Holdings Corporation (MAHLY)
MediPal Holdings Corporation MAHLY
$18.76
0.01
0.05%
September 22, 2026 11:01:06 AM
EST
Volume: 752
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock. In addition, the company offers management and marketing support for insurance pharmacies; logistics contract; veterinary medicines and feed additives; and food processing raw materials, food ingredients, food additives, and chemical product materials. It serves hospitals, clinics, pharmacies, drugstores, home centers, convenience store, supermarkets, veterinary clinics, livestock and fisheries businesses, processed food manufacturers, and other medical facilities. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to MediPal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Chuo, Japan.
Financial Summary
| Share Statistics | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,789.0 | $1,722.4 | 63% |
|
| Shares Out (Mil) | 1.3 | 73.7 | 5% |
|
| Institutional Ownership | 49.8% | 86.8% | 25% |
|
| Float (Mil) | 178.4 | 53.9 | 72% |
|
| Beta | -0.02 | 0.81 | 6% |
|
| Avg Daily Volume (000s) | 2 | 631 | 9% |
|
| Price Change (52-week) |
(8.7%) | 79.2% | 43% |
|
| Growth | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (3.7%) | 10.4% | 10% |
|
| Net Income (5yr) | 4.3% | (0.1%) | 46% |
|
| EPS (5yr) | 6.1% | 3.1% | 40 |
|
| Dividends (5yr) | 1.8% | 0.0% | 67% |
|
| Cash Flow (5yr) | 11.7% | (18.0%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $24,008 | $1,503 | 92% |
|
| Net Income (TTM) (Mil) | $268 | $26 | 71% |
|
| EPS (TTM) | $1.300 | $0.200 | 64% |
|
| Operating Cash Flow (TTM) (Mil) | na | $141 | na |
|
| Net Cash Flow (TTM) (Mil) | na | $5 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $356 | 0% |
|
| Enterprise Value (Q1) (Mil) | $2,865 | $2,284 | 53% |
|
| Valuation | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.02 | na |
|
| P/E | na | 25.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 6.8% | 27.9% | 7% |
|
| Net Margin | 1.2% | 1.3% | 35% |
|
| ROA | 2.2% | 2.2% | 56% |
|
| ROE | 6.6% | 7.0% | 47% |
|
| Liabilities to Assets | 58.6% | 61.3% | 52% |
|
| F-Score | na | 5 | na |
|
MediPal Holdings Corporation did not pass any screens on 9/21/2026.
